Cerity Partners
PVLA

Cerity Partners’s Palvella Therapeutics PVLA Stock Holding History

Cerity Partners’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-129
Closed -$1.89K – 2431
2024
Q1 		$1.89K Hold
129
– – ﹤0.01% 2284
2023
Q4 		$1.88K Buy
+129
New +$2.36K ﹤0.01% 1853
2023
Q3 		– Sell
-129
Closed -$1.71K – 1740
2023
Q2 		$1.71K Hold
129
– – ﹤0.01% 1626
2023
Q1 		$10.1K Hold
129
– – ﹤0.01% 1835
2022
Q4 		$10.7K Sell
129
-1,375
-91% -$110K ﹤0.01% 1468
2022
Q3 		$138K Hold
1,504
– – ﹤0.01% 1094
2022
Q2 		$225K Hold
1,504
– – ﹤0.01% 1037
2022
Q1 		$365K Hold
1,504
– – 0.01% 671
2021
Q4 		$455K Hold
1,504
– – 0.01% 622
2021
Q3 		$622K Hold
1,504
– – 0.01% 423
2021
Q2 		$461K Sell
1,504
-875
-37% -$192K 0.01% 490
2021
Q1 		$489K Buy
2,379
+2,250
+1,744% +$492K 0.01% 456
2020
Q4 		$26K Sell
129
-2,250
-95% -$468K ﹤0.01% 636
2020
Q3 		$394K Hold
2,379
– – 0.02% 356
2020
Q2 		$590K Hold
2,379
– – 0.03% 261
2020
Q1 		$434K Hold
2,379
– – 0.03% 296
2019
Q4 		$689K Hold
2,379
– – 0.04% 288
2019
Q3 		$649K Hold
2,379
– – 0.04% 285
2019
Q2 		$894K Hold
2,379
– – 0.06% 246
2019
Q1 		$638K Hold
2,379
– – 0.04% 297
2018
Q4 		$506K Hold
2,379
– – 0.03% 315
2018
Q3 		$1.07M Hold
2,379
– – 0.07% 236
2018
Q2 		$965K Hold
2,379
– – 0.07% 238
2018
Q1 		$1.3M Buy
2,379
+375
+19% +$232K 0.1% 201
2017
Q4 		$1.21M Hold
2,004
– – 0.08% 216
2017
Q3 		$923K Buy
+2,004
New +$856K 0.07% 242

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cerity Partners's PVLA Position: Q2 2024 in Review

Cerity Partners sold out of Palvella Therapeutics (PVLA) in Q2 2024, closing a stake of 129 shares — an estimated $1.89K sold.

Cerity Partners first reported a position in PVLA in Q3 2017 and held it in 26 quarters. The position peaked at $1.3M in Q1 2018. 21 funds tracked by Wall St. Rank hold PVLA as of Q2 2024.

  • Cerity Partners reported no remaining Palvella Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Cerity Partners sold 129 Palvella Therapeutics shares in Q2 2024, an estimated $1.89K.
  • Cerity Partners first reported a position in Palvella Therapeutics in Q3 2017 and held it in 26 quarters.
  • Cerity Partners's Palvella Therapeutics position peaked at $1.3M in Q1 2018.
  • 21 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2024.

Based on Cerity Partners's 13F filing for Q2 2024, filed 13 Aug 2024.